“Stereotactic Radiotherapy in Combination with the Immunoconjugate Trastuzumab Emtansine in Patients with HER2-Positive Oligometastatic Breast Cancer: Final Results of the Efficacy and Safety Study” (2026) Voprosy onkologii, 72(3), p. OF-2696. doi:10.37469/0507-3758-2026-72-3-OF-2696.